Exclusion criteria:~* Coronary heart disease (CHD) including angina, or peripheral vascular disease including
symptomatic carotid artery disease, or stroke or TIA, as these individuals are likely to require treatment with
lipid-lowering drugs.~* Serious renal disease.~* Uncontrolled diabetes.~* Triglycerides are greater than 500
mg/dL.~* LDL-Cholesterol below 80 mg/dL~* Upper limit for the National Cholesterol Education Program (NCEP)
guidelines for LDL-Cholesterol is 130-190 mg/dL, depending on age and other cardiovascular risk factors.~*
Other indication for the need to treat with lipid-lowering drug.~* Active liver disease or persistent elevation
in serum transaminase.~* Active neoplastic disease (skin tumors other than melanoma are not exclusionary;
subjects with stable prostate cancer may be included at the discretion of the Project Director).~* Use of
another investigational agent within 2 months of the screening visit.~* History of clinically significant
stroke.~* Current evidence or history in the past 2 years of seizures, head injury with loss of consciousness
and/or immediate confusion after the injury.~* Current DSM-IV criteria based diagnosis for major psychiatric
disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse.~* Blindness,
deafness, language difficulties or any other disability which may prevent the subject from participating or
cooperating in the protocol.
